发明申请
US20120122945A1 ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL
有权
[3-(1-(1H-咪唑-4-基)乙基)-2-甲基苯基]甲醇的酯化物
- 专利标题: ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL
- 专利标题(中): [3-(1-(1H-咪唑-4-基)乙基)-2-甲基苯基]甲醇的酯化物
-
申请号: US13233891申请日: 2011-09-15
-
公开(公告)号: US20120122945A1公开(公告)日: 2012-05-17
- 发明人: Ken Chow , Liming Wang , Michael E. Garst , John E. Donello , Daniel W. Gil , Mohammad I. Dibas
- 申请人: Ken Chow , Liming Wang , Michael E. Garst , John E. Donello , Daniel W. Gil , Mohammad I. Dibas
- 申请人地址: US CA Irvine
- 专利权人: ALLERGAN, INC.
- 当前专利权人: ALLERGAN, INC.
- 当前专利权人地址: US CA Irvine
- 主分类号: A61K31/4174
- IPC分类号: A61K31/4174 ; A61P27/02 ; C07D233/64
摘要:
The present invention relates to novel compounds, ester pro-drugs of [3-(1-1H-imidazol-4-yl)ethyl)-2-methylphenyl]methanol, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals in the treatment of conditions mediated by adrenergic receptors.
公开/授权文献
信息查询
IPC分类: